Serum antibody responses to individual viral polypeptides in human rotavirus infections. 1987

L Svensson, and H Sheshberadaran, and S Vene, and E Norrby, and M Grandien, and G Wadell

A radioimmunoprecipitation assay (RIPA) was used to study the serum antibody responses to individual polypeptides that developed after infection with viruses from human rotavirus subgroups I and II. Paired sera from eight children (1 to 8.5 years of age) were used in the study. Although all of the eight acute sera were negative by the complement fixation test, four of them were positive by RIPA, indicating a previous infection by rotavirus. A significant difference in the number of polypeptides immunoprecipitated was seen among the convalescent sera. The number of polypeptides immunoprecipitated was found to be related to previous infection experience. At most, ten different polypeptides were immunoprecipitated: seven structural polypeptides VP1 to VP7 and three non-structural polypeptides, NS1, NS2 and NS3. No sera immunoprecipitated VP8 or VP9. Acute sera positive by RIPA immunoprecipitated up to five polypeptides, VP1, VP2, VP3, VP4 and VP6. One of the non-structural proteins (NS2) was found to be particularly immunogenic, since antibodies to this polypeptide were detected in several convalescent sera. Among the structural proteins VP2 and VP6 were found to be the two immunodominant polypeptides which were recognized by all convalescent sera. Only three convalescent sera immunoprecipitated VP7, the major type-specific antigen responsible for inducing neutralizing antibodies. Three of four originally seronegative children with no reactivity in the convalescent sera to VP7 developed neutralizing antibodies to a single serotype. One child developed antibodies to two serotypes.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D012400 Rotavirus Infections Infection with any of the rotaviruses. Specific infections include human infantile diarrhea, neonatal calf diarrhea, and epidemic diarrhea of infant mice. Infection, Rotavirus,Infections, Rotavirus,Rotavirus Infection
D012401 Rotavirus A genus of REOVIRIDAE, causing acute gastroenteritis in BIRDS and MAMMALS, including humans. Transmission is horizontal and by environmental contamination. Seven species (Rotaviruses A thru G) are recognized. Neonatal Calf Diarrhea Virus,Rotaviruses

Related Publications

L Svensson, and H Sheshberadaran, and S Vene, and E Norrby, and M Grandien, and G Wadell
January 1994, Archives of virology,
L Svensson, and H Sheshberadaran, and S Vene, and E Norrby, and M Grandien, and G Wadell
March 1993, The Journal of infectious diseases,
L Svensson, and H Sheshberadaran, and S Vene, and E Norrby, and M Grandien, and G Wadell
May 1992, Journal of clinical microbiology,
L Svensson, and H Sheshberadaran, and S Vene, and E Norrby, and M Grandien, and G Wadell
January 1993, Journal of medical virology,
L Svensson, and H Sheshberadaran, and S Vene, and E Norrby, and M Grandien, and G Wadell
January 1987, Avian diseases,
L Svensson, and H Sheshberadaran, and S Vene, and E Norrby, and M Grandien, and G Wadell
January 1986, Microbiology and immunology,
L Svensson, and H Sheshberadaran, and S Vene, and E Norrby, and M Grandien, and G Wadell
October 1966, Pediatrics,
L Svensson, and H Sheshberadaran, and S Vene, and E Norrby, and M Grandien, and G Wadell
July 1986, Microbiologica,
L Svensson, and H Sheshberadaran, and S Vene, and E Norrby, and M Grandien, and G Wadell
June 1999, The Journal of general virology,
L Svensson, and H Sheshberadaran, and S Vene, and E Norrby, and M Grandien, and G Wadell
September 1990, Journal of clinical microbiology,
Copied contents to your clipboard!